Genetic Testing Options, News, Personalized Cancer Treatments Vitrakvi approved for NTRK+ cancers | MyOncoPath0 Comments/March 6, 2019FDA approves Vitrakvi in all tumor types with NTRK gene variants Progress… https://myoncopath.com/wp-content/uploads/2019/03/Screen-Shot-2019-03-06-at-11.52.12-AM.png 295 611 hwetzel https://myoncopath.com/wp-content/uploads/2017/07/myoncopath_test_3.svg hwetzel2019-03-06 16:55:032019-05-16 19:22:45Vitrakvi approved for NTRK+ cancers | MyOncoPath